Condition
Chronic Kidney Disease Patients
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Recruiting2
Unknown2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07437729RecruitingPrimary
Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)
NCT06802978RecruitingPrimary
Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06238388Phase 1CompletedPrimary
Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients
NCT03603938Not ApplicableUnknownPrimary
Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
NCT01236820Unknown
A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
Showing all 5 trials